ESI BIO (BioTime) Announces New UK Distribution Agreement with 2BScientific Ltd

ESI BIO’s research products are currently used by stem cell researchers around the world and will now be available exclusively in the UK and Ireland through 2BScientific Ltd.

Alameda, CA, December 09, 2014 – ESI BIO – A Division of BioTime, Inc. specializes in the production of high quality hydrogels, progenitor cells, human embryonic stem cells, and other key tools for stem cell researchers.

Jeffrey Janus, CEO at ESI BIO commented, "We are pleased to hear that 2BScientific would like to be our distributor in the UK market and we expect that we can build a strong partnership in future." James Bernard, CEO of 2BScientific added, "2BScientific is excited to have signed a distribution agreement with ESI BIO to sell all of their stem cell products and services in the United Kingdom and Ireland. We are excited to offer their cell lines and supporting products for stem cell researchers."

About ESI BIO:
ESI BIO - A Division of BioTime, Inc. (“ESI Cell International Pte Ltd.”) is a unique research reagent organization which markets and distributes human embryonic stem cell lines under conditions designed to be compliant with principles of current Good Manufacturing Practices (cGMP), making them suitable for use in clinical research and regenerative medicine. ESI BIO's portfolio includes PureStem® human embryonic progenitors, HyStem® hyaluronan-based hydrogels, antibodies, and small molecules for stem cell differentiation and reprogramming.

ESI BIO's mission is to develop innovative research products that help translate scientific discoveries to the clinic. ESI BIO facilities are located in La Jolla and Alameda, California, with a third location in Singapore.

Learn more at www.esibio.com

About 2B Scientific:
2B Scientific is a specialist distributor of immunological reagents to the UK life science market. 2B Scientific takes a novel approach to life science reagents distribution and provides a wide range of products including antibodies, PCR and flow cytometry reagents, apoptosis assays, proteins and life science consumables.

Learn more at www.2BScientific.com

Contact:
Georgi Manov
2BScientific Ltd
77 Heyford Park
Upper Heyford OX25 5HD
United Kingdom
+44 1869 238033

http://www.2bscientific.com

VisiInc PLC to Acquire VIA3

VisiInc PLC acquisition of VIA3 delivers industry-defining technology platform and marks major push into Australian E-health market.

Arizona, CA and Perth, Western Australia, September 29, 2011 - VisiInc PLC (VZJ) (http://www.deutsche-boerse.com) today announced a definitive agreement to acquire VIA3 (VIA3.com) in an all-stock transaction valued at approximately USD $16 million.

* VisiInc PLC acquisition of VIA3 delivers industry-defining technology platform and marks major push into Australian E-health market.

* Combined technology to spearhead global ultra-secure E-health platform for collaboration of data rich 3D digital media including voice and video conferencing.

The USD $16 million scrip deal to acquire USA Company VIA3 will deliver a powerful cutting edge total collaboration and conferencing platform, with secure 3D file sharing, secure video and audio.

“In acquiring VIA3, the VisiInc PLC offering will significantly accelerate our Australian E-health market thrust as well as fast track numerous global projects relating to health, medical, aerospace, engineering, geosciences, mining and education markets.” said Jacques Blandin CEO Founder of VisiInc PLC.

This integration will provide a total preferred solution for all types of 3D imaging, including X-ray, CT, MRI, ultrasound, optical, and electron microscopy. Fast, efficient rendering of all types of geometry also makes it effective for many other applications, including image processing and analysis, PACS, DICOM, therapy and surgery planning, implant design, forensic medicine, education, training, and even molecular modeling.

“The VisiInc platform is the next evolution in visual communication, and is capable of delivering solutions in both the physical and virtual environment in 3D. With Vistime and VIA3, our combined offering includes unlimited presentations, application sharing, training, whiteboard sessions or demos and instant voice and video conferencing previously not possible in one real time collaboration and conferencing product. VisiInc is currently in trial discussions in both Europe and Eastern Europe with major medical groups” said Jacques Blandin CEO Founder of VisiInc PLC.

Vistime was developed so that engineers, geologists, filmmakers, physicists, healthcare professionals and others can see and work with “elephant-sized” visual files, for the first time anywhere, and collaborate on them with peers to save both time and money.

Vistime is a multi-file format, real-time 3D viewer for retrieval and viewing of large files, including medical imaging systems such as MRIs, scans and sonograms, over any Internet connection, including dial-up.

About VisiInc PLC

Corporate http://www.visiinc.com

Market Cap: € 99 million

Shares on issue: 68 million

Deutsche Bourse: (VZJ)

http://www.boerse-frankfurt.de/EN/index.aspx?pageID=35&ISIN=GB00B59WZW82

VisiInc PLC is a leading software company with development and marketing offices located in the USA. Headquartered in Perth, Australia and registered in the UK, the company listed on the Frankfurt Stock Exchange In May 2011.

Truly a global enterprise, VisiInc’s structure delivers:

* Efficient access to global equity markets

* Access to international software and technology market

* Cost effective Australian-based operations

The company is listed on the Frankfurt Stock Exchange (Deutsche Bourse), which is recognized for its ease of trading and as one of the world’s most efficient capital markets.

Australia is currently moving toward an E-health system where secure electronic records and medical file management and sharing will radically improve health care and generate up to an estimated $4 billion in software sales over the coming six years.

June 1st 2011,VisiInc entered into an agreement to launch MMRGlobal’s patented consumer and professional health IT products and services, including MMRPro for healthcare professionals (http://www.mmrprovideos.com) and the MyMedicalRecords Personal Health Record (PHR) (http://www.mmrvideos.com), on the Visi™ platform utilizing the Vistime product.

Through it’s evolutionary Visi™ platform, VisiInc operates Vistime. Vistime is rapidly capturing global market share of major verticals such as Healthcare, Government, Engineering and Architecture, Mining, Oil & Gas, Exploration, Energy, Education, Advertising & Media and online Video Conferencing.

Through its unprecedented rapid visual rendering capabilities, the Vistime system (http://www.vistime.com) allows all end users to simultaneously view, manipulate, and explore multi-dimensional data visualizations of any file type and of any size, in real-time without any resolution degradation. The system eliminates the lag time barrier that exists with other viewers. As a result, Vistime is the first in the world to enable real-time collaboration of complex, data-rich visual files and 3D media. For more information, visit http://www.visiinc.com.

Forward-Looking Statements

This Press Release may contain certain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates", "believes", "estimates", "expects", "plans", "intends", "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

VisiInc Contact

Glenn Weiland, Senior Executive Director / Senior Vice President Global Communications

Mobile +61 408 909 553 glenn.weiland@visiinc.com

Corporate Office & Principal

12th Floor Exchange House, 68 St Georges Terrace

Perth. WA 6000 Australia

USA Office 4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 9001

Contact:

Glenn Weiland

VisiInc PLC

4401 Wilshire Blvd

2nd Floor

Los Angeles, CA 9001

+61 408 909 553

glenn.weiland@visiinc.com

http://www.visiinc.com

Online Gaming and Entertainment Company 2UP Enters Agreement to buy Online Pokies/slo

Listed online gaming and entertainment company 2UP Gaming PLC (2GM:GR) has entered into an agreement to purchase an online pokies/slots affiliate business that is part of a global USD$6.7 billion industry.

London, UK, June 26, 2011 - The agreement, subject to due-diligence, is for the WebPokies.com and OnlinePokies.com.au domains that provide links to internet gaming services for a worldwide audience.

2UP managing director Peter Bentley says the purchase is an excellent strategic fit for the company providing immediate cash flow.

"A report released earlier this year noted online poker and casino operations account for almost half of the USD$13.49 billion international internet gambling market," Mr Bentley says.

"Entering the affiliate business forms part of 2UP’s long-term plans to become a major international online gaming and entertainment company.

"This purchase is for a long-established business with solid earnings, however we believe the revenues can be significantly increased through 2UP’s distribution network in Asia, India and around the world."

Affiliate sites act as portals to enable visitors to locate and access online slot machines or pokies by redirecting them to casinos who pay for either traffic or a sale of their product. Many online casinos have affiliate programs driving traffic to their chosen domain.

OnlinePokies.com.au commenced in 2006 and acquired WebPokies.com in 2010. Both domains have demonstrated cumulative growth in players, revenues and earnings.

Mr Bentley says online gaming is currently experiencing exponential growth with signs for the sector to increase dramatically over the next few years.

"The growth of online gaming is particularly relevant in Europe, where governments are seeking to capture tax revenues by regulating the market," Mr Bentley says.

"A recent report by KPMG states cash-strapped governments around the world may consider relaxing current online gaming rules and restrictions in order to provide a much needed boost to tax revenues.

"If promoted properly, affiliate businesses can be extremely profitable, especially if they have standout URL’s such as these."

2UP, with offices in the UK and Australia, listed on the Frankfurt Stock Exchange in early May and has already seen a solid growth in its share price.

It recently finalised a partnership deal with one of Asia’s largest pool betting companies ToteDaddy.

The deal will see 2UP’s range of popular gaming and wagering products made available to ToteDaddy’s substantial global membership base providing 2UP with immediate high-traffic exposure to the Asian online gaming market.

The company has an online gaming license granted until 2025 to capitalise on its market positioning.

The first game to be released from 2UP is its live streaming and animated versions of the classic Australian coin-tossing game.

This will be underpinned by other unique and established gaming and wagering options to be released as part of its growth plans.

For more information visit www.2UP.com or email investor-relations@wedgewoodcommunications.com

Contact:

Bruce Nelson

2UP

Office 11

10 Great Russel Street

London, WC1B 3BQ

+61 (0)423 403 449

enquiries@2up.com

http://www.2up.com